Canada markets closed
  • S&P/TSX

    19,370.99
    +489.80 (+2.59%)
     
  • S&P 500

    3,790.93
    +112.50 (+3.06%)
     
  • DOW

    30,316.32
    +825.43 (+2.80%)
     
  • CAD/USD

    0.7404
    +0.0002 (+0.02%)
     
  • CRUDE OIL

    86.38
    -0.14 (-0.16%)
     
  • BTC-CAD

    27,421.90
    +752.02 (+2.82%)
     
  • CMC Crypto 200

    460.91
    +15.47 (+3.47%)
     
  • GOLD FUTURES

    1,733.90
    +3.40 (+0.20%)
     
  • RUSSELL 2000

    1,775.77
    +66.90 (+3.91%)
     
  • 10-Yr Bond

    3.6170
    -0.0340 (-0.93%)
     
  • NASDAQ futures

    11,623.25
    -17.50 (-0.15%)
     
  • VOLATILITY

    29.07
    -1.03 (-3.42%)
     
  • FTSE

    7,086.46
    +177.70 (+2.57%)
     
  • NIKKEI 225

    26,992.21
    +776.42 (+2.96%)
     
  • CAD/EUR

    0.7413
    +0.0003 (+0.04%)
     

This Is the Boldest Prediction Yet From Tilray's CEO

·4 min read

Tilray Brands (NASDAQ: TLRY) CEO Irwin Simon is no stranger to making lofty projections. Simon's goal to hit $4 billion in annual revenue assumes that legalization takes place in Europe and the U.S. And in a recent interview with CNBC, he said that once that happens, there won't be another company out there "that will have the assets and the ability to grow and build brands like we will." Tilray also has convertible notes in multi-state marijuana operator MedMen Enterprises that it could seek to convert and take a stake in once legalization takes place (currently it would run into issues owning a stake in the business given the federal ban on pot in the U.S.).